Xeris Biopharma Holdings, Inc. (XERS)
6.53
-0.10
(-1.51%)
USD |
NASDAQ |
May 08, 16:00
6.53
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Total Assets (Quarterly) : 392.01M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Zoetis, Inc. | 15.15B |
| Harrow, Inc. | 405.21M |
| Corcept Therapeutics, Inc. | 814.88M |
| Assertio Holdings, Inc. | 211.30M |
| Johnson & Johnson | 200.89B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 379.00M |
| Shareholders Equity (Quarterly) | 13.01M |
| Debt to Equity Ratio | 19.87 |
| Current Ratio | 2.122 |
| Net Debt Paydown Yield | 0.26% |